Abstract
Since the Edmonton trials, insulin independence can reproducibly be achieved after islet transplantation. However, a majority of patients resume insulin treatment in the first 5 years after transplantation. Several mechanisms have been proposed but are difficult to pinpoint in one particular patient. Current tools for the metabolic monitoring of islet grafts indicate islet dysfunction when it is too late to take action. Noninvasive imaging of transplanted islets could be used to study β-cell mass and β-cell function just after infusion, during vascularization or autoimmune and alloimmune attacks. This review will focus on the most recent advances in various imaging techniques (bioluminescence imaging, fluorescence optical imaging, MRI, and positron emission tomography). Emphasis will be placed on pertinent approaches for translation to human practice.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–8.
Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol. 2005;77(5):587–97.
Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54(7):2060–9.
Roelen DL, Huurman VA, Hilbrands R, et al. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Clin Exp Immunol. 2009;156(1):141–8.
Huurman VA, Velthuis JH, Hilbrands R, et al. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am J Transplant. 2009;9(2):382–8.
Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One. 2008;3(6):e2435.
Bellin MD, Sutherland DE, Beilman GJ, et al. Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants. Transplantation. 2011;91(3):367–72.
Niclauss N, Bosco D, Morel P, et al. Rapamycin impairs proliferation of transplanted islet beta cells. Transplantation. 2011;91(7):714–22.
Berney T, Toso C. Monitoring of the islet graft. Diabetes Metab. 2006;32(5 Pt 2):503–12.
Ferrari-Lacraz S, Berney T, Morel P, et al. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation. Transplantation. 2008;86(2):357–9.
Bosi E, Braghi S, Maffi P, et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes. 2001;50(11):2464–71.
Kessler L, Parissiadis A, Bayle F, et al. Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and IV immunoglobulin therapy. Am J Transplant. 2009;9(8):1961–6.
Lacotte S, Berney T, Shapiro AJ, Toso C. Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events. Expert Opin Biol Ther. 2011;11(1):55–66.
Toso C, Isse K, Demetris AJ, et al. Histologic graft assessment after clinical islet transplantation. Transplantation. 2009;88(11):1286–93.
Gaglia JL. Noninvasive imaging of islet transplantation and rejection. Curr Diab Rep. 2007;7(4):309–13.
Fowler M, Virostko J, Chen Z, et al. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation. 2005;79(7):768–76.
• Chen X, X Zhang, C Larson, et al. Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of antilymphocyte serum treatment of rejection. Transplantation. 2008;85(9):1246–52. This paper demonstrates that allogeneic islet grafts can be salvaged by ALS injection when rejection diagnosis was based on bioluminescence signal before rise in glycemia.
Park SY, Wang X, Chen Z, et al. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis. 2005;43(2):80–6.
Virostko J, Radhika A, Poffenberger G, et al. Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation. Mol Imaging Biol. 2010;12(1):42–53.
Evgenov NV, Medarova Z, Dai G, et al. In vivo imaging of islet transplantation. Nat Med. 2006;12(1):144–8.
Speier S, Nyqvist D, Cabrera O, et al. Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med. 2008;14(5):574–8.
Perez VL, A Caicedo, DM Berman, et al. The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes. Diabetologia. 54(5):1121–26.
Jirak D, Kriz J, Herynek V, et al. MRI of transplanted pancreatic islets. Magn Reson Med. 2004;52(6):1228–33.
Ris F, Lepetit-Coiffe M, Meda P, et al. Assessment of human islet labeling with clinical grade iron nanoparticles prior to transplantation for graft monitoring by MRI. Cell Transplant. 2010;19(12):1573–85.
Malosio ML, Esposito A, Poletti A. Improving the procedure for detection of intrahepatic transplanted islets by magnetic resonance imaging. Am J Transplant. 2009;9(10):2372–82.
Evgenov NV, Medarova Z, Pratt J, et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes. 2006;55(9):2419–28.
Kriz J, Jirak D, Girman P, et al. Magnetic resonance imaging of pancreatic islets in tolerance and rejection. Transplantation. 2005;80(11):1596–603.
Jiao Y, Peng ZH, Zhang JY, et al. Liposome-mediated transfer can improve the efficacy of islet labeling with superparamagnetic iron oxide. Transplant Proc. 2008;40(10):3615–8.
Zhang S, He H, Lu W, et al. Tracking intrahepatically transplanted islets labeled with Feridex-polyethyleneimine complex using a clinical 3.0-T magnetic resonance imaging scanner. Pancreas. 2009;38(3):293–302.
Evgenov NV, Pratt J, Pantazopoulos P, Moore A. Effects of glucose toxicity and islet purity on in vivo magnetic resonance imaging of transplanted pancreatic islets. Transplantation. 2008;85(8):1091–8.
• Saudek F, D Jirak, P Girman, et al. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation. 2010;90(12):1602–06. This is a pilot study of SPIO-labeled islet imaging in humans. Islets could be observed in the majority of subjects. The signal strongly decreased 1 week after transplantation and remained stable up to 24 weeks, but no correlation was observed between the MRI signal and the number of transplanted islets.
Medarova Z, Vallabhajosyula P, Tena A, et al. In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates. Transplantation. 2009;87(11):1659–66.
• Crowe LA, F Ris, S Nielles-Vallespin, et al. A novel method for quantitative monitoring of transplanted islets of langerhans by positive contrast magnetic resonance imaging. Am J Transplant. 2011;11(6):1158–68. This discusses a new semiautomated quantification method of MRI signal coming from SPIO-labeled islets that can be translated in humans.
Toso C, Vallee JP, Morel P, et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant. 2008;8(3):701–6.
Juang JH, Wang JJ, Shen CR, et al. Magnetic resonance imaging of transplanted mouse islets labeled with chitosan-coated superparamagnetic iron oxide nanoparticles. Transplant Proc. 2010;42(6):2104–8.
• Lee N, H Kim, SH Choi, et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc Natl Acad Sci USA. 2011;108(7):2662–67. This discusses a new iron particle for pretransplantation islet labeling giving a stronger hyposignal on T2-weighted sequences than Feridex.
Biancone L, Crich SG, Cantaluppi V, et al. Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation. NMR Biomed. 2007;20(1):40–8.
Barnett BP, Arepally A, Karmarkar PV, et al. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med. 2007;13(8):986–91.
• Barnett BP, J Ruiz-Cabello, P Hota, et al. Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology. 2011;258(1):182–91. Describes islet encapsulation with the addition of perfluorocarbon inside the capsule, acting as a multimodal contrast agent, detected by MRI, ultrasonography, and CT imaging.
Antkowiak PF, Tersey SA, Carter JD, et al. Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab. 2009;296(3):E573–8.
Hathout E, Sowers L, Wang R, et al. In vivo magnetic resonance imaging of vascularization in islet transplantation. Transpl Int. 2007;20(12):1059–65.
Chan NK, Obenaus A, Tan A, et al. Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. Islets. 2009;1(3):249–55.
Sakata N, Obenaus A, Chan NK, et al. Correlation between angiogenesis and islet graft function in diabetic mice: magnetic resonance imaging assessment. J Hepatobiliary Pancreat Sci. 2010;17(5):692–700.
Denis MC, Mahmood U, Benoist C, et al. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci USA. 2004;101(34):12634–9.
Toso C, Zaidi H, Morel P, et al. Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. Transplantation. 2005;79(3):353–5.
• Eriksson O, T Eich, A Sundin, et al. Positron emission tomography in clinical islet transplantation. Am J Transplant. 2009;9(12):2816–24. Using [ 18 F]FDG-prelabeled islets, authors observed that 25% of the injected radioactivity was lost just after infusion, suggesting loss of islets during procedure. This technique can also study the islet distribution in the human liver.
Lu Y, Dang H, Middleton B, et al. Noninvasive imaging of islet grafts using positron-emission tomography. Proc Natl Acad Sci USA. 2006;103(30):11294–9.
Kim SJ, Doudet DJ, Studenov AR, et al. Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival. Nat Med. 2006;12(12):1423–8.
Lu Y, Dang H, Middleton B, et al. Long-term monitoring of transplanted islets using positron emission tomography. Mol Ther. 2006;14(6):851–6.
•• Wu Z, F Kandeel. Radionuclide probes for molecular imaging of pancreatic beta-cells. Adv Drug Deliv Rev. 2010;62(11):1125–38. This is a comprehensive review of potential nuclear probes for PET β-cell imaging.
Wild D, Wicki A, Mansi R, et al. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med. 2010;51(7):1059–67.
• Christ E, D Wild, F Forrer, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab. 2009;94(11):4398–405. PET GLP-1 receptor imaging with [111In]DOTA-exendin-4 probe is effective to diagnose pancreas insulinoma and could be a potential technique for transplanted islet imaging.
Pattou F, Kerr-Conte J, Wild D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle. N Engl J Med. 2010;363(13):1289–90.
Ris F, Toso C, Morel P, et al. Imaging of islets grafts. Curr Opin Organ Transplant. 2007;12:659–63.
Sweet IR, Cook DL, Lernmark A, et al. Non-invasive imaging of beta cell mass: a quantitative analysis. Diabetes Technol Ther. 2004;6(5):652–9.
Acknowledgments
C. Toso was supported by the Swiss National Science Foundation (SCORE grant 3232230–126233). T. Berney was supported by the Swiss National Science Foundation (grant 320030-127583/1) and Insuleman.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Borot, S., Crowe, L.A., Toso, C. et al. Noninvasive Imaging Techniques in Islet Transplantation. Curr Diab Rep 11, 375–383 (2011). https://doi.org/10.1007/s11892-011-0215-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-011-0215-x